$108 Million is the total value of Velan Capital Investment Management LP's 23 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LNTH | Sell | LANTHEUS HLDGS INC | $17,699,000 | -1.5% | 320,000 | -48.5% | 16.42% | +17.8% |
| RDUS | Buy | RADIUS HEALTH INC | $12,552,000 | +558.9% | 1,421,500 | +416.4% | 11.65% | +688.1% |
| ADMA | Buy | ADMA BIOLOGICS INC | $10,656,000 | +40.0% | 5,822,798 | +7.9% | 9.89% | +67.4% |
| JASPER THERAPEUTICS INC | $10,180,000 | -55.6% | 3,219,036 | 0.0% | 9.45% | -46.9% | ||
| IMCR | IMMUNOCORE HLDGS PLCads | $8,772,000 | -12.7% | 293,385 | 0.0% | 8.14% | +4.4% | |
| Sell | SCIENCE 37 HOLDINGS INC | $6,274,000 | -58.1% | 1,172,661 | -2.3% | 5.82% | -49.9% | |
| ATRS | New | ANTARES PHARMA INC | $5,523,000 | – | 1,346,971 | +100.0% | 5.12% | – |
| TELA | Buy | TELA BIO INC | $5,250,000 | +36.7% | 451,400 | +50.5% | 4.87% | +63.5% |
| OPTN | New | OPTINOSE INC | $4,940,000 | – | 2,000,000 | +100.0% | 4.58% | – |
| THE ONCOLOGY INSTITUTE INC | $4,278,000 | -26.9% | 600,000 | 0.0% | 3.97% | -12.6% | ||
| Sell | NYXOAH S A | $3,119,000 | -23.7% | 162,966 | -8.3% | 2.89% | -8.8% | |
| CFMS | Buy | CONFORMIS INC | $2,897,000 | -8.7% | 4,644,507 | +11.5% | 2.69% | +9.2% |
| CSU | SONIDA SENIOR LIVING INC | $2,744,000 | +16.3% | 82,832 | 0.0% | 2.55% | +39.0% | |
| RAPT | RAPT THERAPEUTICS INC | $2,419,000 | -40.1% | 110,000 | 0.0% | 2.24% | -28.4% | |
| HCSG | HEALTHCARE SVCS GROUP INC | $2,284,000 | +4.4% | 123,000 | 0.0% | 2.12% | +24.9% | |
| CARIBOU BIOSCIENCES INC | $1,934,000 | -39.2% | 210,695 | 0.0% | 1.80% | -27.2% | ||
| SOMALOGIC INC | $1,887,000 | -31.1% | 235,300 | 0.0% | 1.75% | -17.6% | ||
| CMRX | CHIMERIX INC | $1,832,000 | -28.8% | 400,000 | 0.0% | 1.70% | -14.8% | |
| VTRS | New | VIATRIS INC | $1,088,000 | – | 100,000 | +100.0% | 1.01% | – |
| RZLT | REZOLUTE INC | $1,014,000 | -29.3% | 300,000 | 0.0% | 0.94% | -15.5% | |
| New | 2SEVENTY BIO INC | $404,000 | – | 23,657 | +100.0% | 0.38% | – | |
| GFORWS | GRAF ACQUISITION CORP IV*w exp 05/31/202 | $11,000 | -52.2% | 20,000 | 0.0% | 0.01% | -44.4% | |
| SOMALOGIC INC*w exp 08/31/202 | $4,000 | -42.9% | 2,060 | 0.0% | 0.00% | -20.0% | ||
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -1,125 | -100.0% | -0.02% | – |
| Exit | ENVVENO MEDICAL CORPORATION | $0 | – | -74,478 | -100.0% | -0.38% | – | |
| Exit | GRAF ACQUISITION CORP IV | $0 | – | -86,506 | -100.0% | -0.65% | – | |
| CRIS | Exit | CURIS INC | $0 | – | -250,000 | -100.0% | -0.92% | – |
| Exit | XERIS BIOPHARMA HOLDINGS INCcall | $0 | – | -446,500 | -100.0% | -1.02% | – | |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -747,768 | -100.0% | -1.55% | – |
| NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -4,328,306 | -100.0% | -3.29% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCcall | $0 | – | -150,000 | -100.0% | -6.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
| ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
| JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
| TELA BIO INC | 8 | Q3 2023 | 7.6% |
| REZOLUTE INC | 8 | Q3 2023 | 1.3% |
| OPTINOSE INC | 7 | Q3 2023 | 7.9% |
| IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
| ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
| QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
| SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-03-28 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-09 |
| SC 13D/A | 2024-02-09 |
| SC 13G/A | 2024-01-29 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-04 |
| 4 | 2023-08-17 |
| SC 13D/A | 2023-08-16 |
| 13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.